AzTrials
AzTrials

Anterior Cruciate Ligament ReconstructionAVON ACLNCT03648944

Accelerated vs Non-Accelerated Rehabilitation After Anterior Cruciate Ligament Reconstruction: A Pilot Study

A study testing Accelerated Rehabillitation and Non-Accelerated Rehabillitation in people with Anterior Cruciate Ligament Reconstruction, run by North Bristol NHS Trust at 1 site in United Kingdom.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study is comparing accelerated versus nonaccelerated rehabilitation following ACL reconstruction. Patients undergoing ACL reconstruction will be randomly allocated to one of the two rehabillitation pathways. They will then be monitored over a 15 month period. Read more about this study

Who is it for?
Ages 16 years and older
What is being tested?
Accelerated Rehabillitation and Non-Accelerated Rehabillitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
7 participants
Where
1 siteUnited Kingdom
Study dates
Dec 2014to 19 Sep 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Male or female patients aged 16 years or over, listed for primary ACL reconstruction using hamstring grafts at North Bristol NHS Trust.

Who cannot join

  • Patients listed for double bundle ACL reconstruction.
  • Patients listed for multiple ligament reconstruction.
  • Patients listed for revision reconstructive surgery of the knee.
  • Previous history of lower limb arthroplasty.
  • Previous history of knee injury in either knee, e.g. meniscal tears, previous ligament injuries.
  • Patients unable to understand or read English (the outcome measures being utilised have been validated or published in the English language only).
Show all 9Show fewer
  • Patients unable to comply with the study protocol.
  • Patients unable to attend for rehabilitation at North Bristol NHS Trust.
  • Meniscal repairs resulting in subsequent modification to the rehabilitation protocol (e.g. altered weight bearing, brace).

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • North Bristol NHS Trust

    Bristol, BS10 5NB

Other trials in United Kingdom

About this study

This study is comparing accelerated versus nonaccelerated rehabilitation following ACL reconstruction. Patients undergoing ACL reconstruction will be randomly allocated to one of the two rehabillitation pathways. They will then be monitored over a 15 month period.

Read the detailed description

The anterior cruciate ligament (ACL) is a vital structure within the knee that provides the stability of the joint. Injury to the ACL is a common injury of the knee affecting young adults, usually whilst playing sport.

Surgical reconstruction of complete ACL rupture aims to restore stability of the knee, reduce pain and swelling, limit future arthritic change, maximise knee function and allow patients to return to preinjury recreational and sporting activity. It has been suggested that the success of an ACL reconstruction is dependent upon the postoperative rehabilitation process.

There is no consensus on the best rehabilitation following ACL reconstruction. Traditional, nonaccelerated, rehabilitation programmes emphasise protection of the ACL graft, modelled on the stages of graft healing. This includes postoperative immobilisation, limiting how much the knee can be straightened, restricted weight bearing and delayed return to activity with most patients returning to activity at 1 year. Complications have however been identified with nonaccelerated rehabilitation. This includes ongoing muscle weakness, inability to fully straighten the knee, and knee cap pain at 1 year followup. To address these issues alternative, accelerated, rehabilitation programmes have been developed. These have included allowing full movement, earlier weight bearing and earlier return to activity, with no adverse sequalae.

The uncertainty in the benefit of accelerated rehabilitation over conventional nonaccelerated protocols warrants further investigation in order determine whether accelerated protocols improve knee muscle function and clinical outcome in the longterm, and provide a more effective practice for treating patients following ACL reconstruction, or whether they pose an increased risk of reinjury by permitting early return to higher level activity.

This study is a single centre randomized controlled trial comparing accelerated versus nonaccelerated rehabilitation protocols with the use of clinical and patient reported outcome measures over a 15month period following ACL reconstruction.

Being tested
Accelerated Rehabillitation, Non-Accelerated Rehabillitation
Keywords
Rehabilitation Outcome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Accelerated RehabillitationOther

  • Non-Accelerated RehabillitationOther

Study groups in NCT03648944
Study groupRoleWhat they receive
Accelerated RehabilitationExperimentalParticipants in this arm will have fewer restrictions on their mobility post-operatively and will be permitted to return to more active sporting activities quicker.
Receives: Other: Accelerated Rehabillitation
Non-AcceleratedActive comparatorParticipants in this arm will be fitted with a knee brace and be restricted in their weight bearing post-operatively. They will also be restricted from returning to active sporting activities too quickly.
Receives: Other: Non-Accelerated Rehabillitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. IKDC data completion

    As a measure of the feasibility of the study design

    Measured: 15 months

  2. KOOS data completion

    As a measure of the feasibility of the study design

    Measured: 15 months

  3. Tegner data completion

    As a measure of the feasibility of the study design

    Measured: 15 months

  4. EQ5D data completion

    As a measure of the feasibility of the study design

    Measured: 15 months

  5. Anterior/Posterior knee translation completion

    As a measure of the feasibility of the study design

    Measured: 15 months

  6. Lower Limb Symmetry completion

    As a measure of the feasibility of the study design

    Measured: 15 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2018
  2. Study startDec 2014
  3. Primary completion19 Sep 2016
  4. Study completion19 Sep 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
7 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03648944
Sponsor's protocol ID
R&I 3181
Acronym
AVON ACL
Status last verified
Oct 2014
First submitted
29 Jan 2015
Last updated
28 Aug 2018
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Accelerated Rehabillitation and Non-Accelerated Rehabillitation in people with Anterior Cruciate Ligament Reconstruction, run by North Bristol NHS Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 28 Aug 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early. Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

IKDC data completion (time frame: 15 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in